ASO Visual Abstract: Evaluation of Survival and Postoperative Radiation among Patients with Advanced Medullary Thyroid Carcinoma: An Analysis of the National Cancer Database Thomas J. OwVikas MehtaHaejin In ASO Visual Abstract 09 January 2022 Pages: 2592 - 2593
Predictive Score of Nodal Involvement in Endometrial Cancer Patients: A Large Multicentre Series Vito Andrea CapozziGiulio SozziRoberto Berretta Gynecologic Oncology 26 November 2021 Pages: 2594 - 2599
ASO Author Reflections: How Long will We Perform Lymphadenectomy in Endometrial Cancer Patients? Vito Andrea CapozziGiulio SozziRoberto Berretta ASO Author Reflections 19 November 2021 Pages: 2600 - 2601
Predictive Score of Nodal Involvement in Endometrial Cancer Patients: A Large, Multicenter Series Vito Andrea CapozziGiulio SozziRoberto Berretta ASO Visual Abstract 07 January 2022 Pages: 2602 - 2602
Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer M. LoverroR. ErgastiV. Gallotta Gynecologic Oncology 08 January 2022 Pages: 2603 - 2604
ASO Author Reflections: Minimally Invasive Secondary Cytoreductive Surgery for Ovarian Cancer Lymph Node Recurrence: Shaping Treatment with All Arrows in our Quiver Matteo LoverroRaffaella ErgastiValerio Gallotta ASO Author Reflections 22 January 2022 Pages: 2605 - 2606
Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant Pathology Ayaz Ahmed MemonChintamani GodboleNorman J. Carr Peritoneal Surface Malignancy 03 November 2021 Pages: 2607 - 2613
ASO Author Reflections: Discordant Pathology in Pseudomyxoma Peritonei and Its Impact on Survival following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Chintamani GodboleAyaz Ahmed MemonNorman John Carr ASO Author Reflections 05 November 2021 Pages: 2614 - 2615
ASO Visual Abstract: Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant Pathology Ayaz Ahmed MemonChintamani GodboleNorman J. Carr ASO Visual Abstract 06 January 2022 Pages: 2616 - 2616
Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial Cascales Campos Pedro AntonioGonzález Gil AlidaGil Martínez José Peritoneal Surface Malignancy 23 November 2021 Pages: 2617 - 2625
ASO Author Reflections: HIPEC with Cisplatin Improves Prognosis in Advanced Ovarian Cancer after Neoadjuvant Chemotherapy Pedro Antonio Cascales CamposAlida González Gil ASO Author Reflections 03 January 2022 Pages: 2626 - 2627
ASO Visual Abstract: Cytoreductive Surgery with or Without HIPEC after Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase III Clinical Trial Pedro Antonio Cascales CamposAlida González GilJosé Gil Martínez ASO Visual Abstract 16 January 2022 Pages: 2628 - 2629
Failure to Thrive Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Causes and Consequences Caroline J. RieserJurgis AlvikasM. Haroon A. Choudry Peritoneal Surface Malignancy 06 January 2022 Pages: 2630 - 2639
ASO Visual Abstract: Failure to Thrive Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Causes and Consequences Caroline J. RieserJurgis AlvikasM. Haroon A. Choudry ASO Visual Abstract 24 January 2022 Pages: 2640 - 2640
Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Christopher W. MangieriOmeed MoavenEdward A. Levine Peritoneal Surface Malignancy 13 January 2022 Pages: 2641 - 2648
ASO Author Reflections: Neoadjuvant Chemotherapy for High-Grade Appendiceal Neoplasms Before Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Closer to Evidence-Based Practice? Christopher W. MangieriEdward A. Levine ASO Author Reflections 10 January 2022 Pages: 2649 - 2650
ASO Visual Abstract: Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Christopher W. MangieriOmeed MoavenEdward A. Levine ASO Visual Abstract 10 January 2022 Pages: 2651 - 2651
Functional Cerebral MRI Evaluation of Integration of Breast Reconstruction into the Body Schema Claudia RégisMarie-Cécile Le DeleyChristine Delmaire Reconstructive Oncology 27 November 2021 Pages: 2652 - 2661
ASO Visual Abstract: Functional Cerebral MRI Evaluation of the Integration of Breast Reconstruction into the Body Schema Claudia RégisMarie-Cécile Le DeleyChristine Delmaire ASO Visual Abstract 01 December 2021 Pages: 2662 - 2662
Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma Tomoki AbeTaro OshikiriYoshihiro Kakeji Thoracic Oncology 22 November 2021 Pages: 2663 - 2671
ASO Visual Abstract: Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma Tomoki AbeTaro OshikiriYoshihiro Kakeji ASO Visual Abstract 09 January 2022 Pages: 2672 - 2672
Clinical Significance of Endoscopic Response Evaluation to Predict the Distribution of Residual Tumor after Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Satoru MatsudaHirofumi KawakuboYuko Kitagawa Thoracic Oncology 23 November 2021 Pages: 2673 - 2680
ASO Author Refections: Evaluation of Endoscopic Response After Neoadjuvant Chemotherapy Guides Distribution of Residual Diseases for Esophageal Squamous Cell Carcinoma Satoru MatsudaHirofumi KawakuboYuko Kitagawa ASO Author Reflections 11 November 2021 Pages: 2681 - 2682
ASO Visual Abstract: Clinical Significance of Endoscopic Response Evaluation to Predict the Distribution of Residual Tumor After Neoadjuvant Chemotherapy for Esophageal Squamous cell Carcinoma Satoru MatsudaHirofumi KawakuboYuko Kitagawa ASO Visual Abstract 06 January 2022 Pages: 2683 - 2684
Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases Kazuharu ChibaTatsuo HataMichiaki Unno Translational Research 05 November 2021 Pages: 2685 - 2697
ASO Visual Abstract: Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-abdominal Metastases Kazuharu ChibaTatsuo HataMichiaki Unno ASO Visual Abstract 12 November 2021 Pages: 2698 - 2698
SLC7A9 as a Potential Biomarker for Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma Hayato BabaMitsuro KandaTsutomu Fujii Translational Research 12 November 2021 Pages: 2699 - 2709
ASO Visual Abstract: SLC7A9 as a Potential Biomarker for Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma Hayato BabaMitsuro KandaTsutomu Fujii ASO Visual Abstract 11 January 2022 Pages: 2710 - 2710
Mac-2-Binding Protein Glycosylation Isomer as a Novel Predictor of Hepatocellular Carcinoma Recurrence in Patients with Hepatitis C Virus Eradication Kyohei YugawaTakashi MaedaKenkichi Hashimoto Translational Research 02 November 2021 Pages: 2711 - 2719
Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome Sami ShoucairJoseph R. HabibJun Yu Translational Research 18 November 2021 Pages: 2720 - 2731
ASO Visual Abstract: Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Shows KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome Sami ShoucairJoseph R. HabibJun Yu ASO Visual Abstract 13 January 2022 Pages: 2732 - 2733